Dr. Rachita Navara is a bioengineer and cardiologist subspecializing in electrophysiology – debugging circuits in the heart. Her interest in EP emerged during bioengineering training at the innovative Olin College of Engineering, where she consulted for companies such as Boston Scientific and Preserve as an undergraduate student. In medical school at UT Southwestern, she harnessed her engineering skills to analyze intravascular ultrasound data and became a lead author on the four-year ACE-CTO clinical trial. In internal medicine residency at Stanford University, Dr. Navara was accepted into the inaugural Biodesign Pathway of Distinction and won first place for her innovative solution to post-cardiac arrest medication management. She was honored with multiple research awards and has been internationally recognized for her research on atrial fibrillation mechanisms.